Normocomplementaemic urticarial vasculitis: effective treatment with omalizumab

We report two patients with normocomplementaemic urticarial vasculitis with impressive response to omalizumab. This contrasts recent reports on hypocomplementaemic urticarial vasculitis syndrome, highlighting the need for clinical trials of omalizumab in normocomplementaemic urticarial vasculitis.

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Transl Allergy
Main Authors: de Brito, Marianne, Huebner, Gisela, Murrell, DedeeF, Bullpitt, Peter, Hartmann, Karin
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2018
Fag:
Letter to the Editor
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6149008/
https://ncbi.nlm.nih.gov/pubmed/30258566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13601-018-0222-y
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker